Outputs (14)

Band 3, an essential red blood cell hub of activity (2021)
Journal Article

The red blood cell (RBC) is a marvel of cellular evolutionary specialization. Whilst often considered simplistic owing to its absence of nuclei and other cellular organelles, this inability to respond transcriptionally and to replenish components thr... Read More about Band 3, an essential red blood cell hub of activity.

The discovery of a novel antimetastatic Bcl3 inhibitor (2021)
Journal Article

The development of antimetastatic drugs is an urgent healthcare priority for patients with cancer, because metastasis is thought to account for around 90% of cancer deaths. Current antimetastatic treatment options are limited and often associated wit... Read More about The discovery of a novel antimetastatic Bcl3 inhibitor.

FLASH proton therapy (2021)
Presentation / Conference Contribution

Conference teaching session: The FLASH effect is a normal tissue sparing induced by ultra-high dose rate irradiation. This effect has the potential to create a step change in the therapeutic ratio, however the exact parameters which induce normal tis... Read More about FLASH proton therapy.

Cleaning the cellular factory: Deletion of McrA in Aspergillus oryzae NSAR1 and the generation of a novel kojic acid deficient strain for cleaner heterologous production of secondary metabolites (2021)
Journal Article

The use of filamentous fungi as cellular factories, where natural product pathways can be refactored and expressed in a host strain, continues to aid the field of natural product discovery. Much work has been done to develop host strains which are ge... Read More about Cleaning the cellular factory: Deletion of McrA in Aspergillus oryzae NSAR1 and the generation of a novel kojic acid deficient strain for cleaner heterologous production of secondary metabolites.